Literature DB >> 12691844

The DMWD protein from the myotonic dystrophy (DM1) gene region is developmentally regulated and is present most prominently in synapse-dense brain areas.

Jolanda H A M Westerlaken1, Catharina E E M Van der Zee, Wilma Peters, Bé Wieringa.   

Abstract

The DMWD gene is located in the myotonic dystrophy (DM1) gene cluster on 19q, just upstream of the DMPK gene. RNA and protein products of this gene are ubiquitously expressed in all adult tissues, but occur most abundant in testes and brain. Altered expression of DMWD mRNA in DM1 patients has been observed, suggesting a role of the DMWD gene products in disease manifestation. Here we focussed on DMWD expression in mouse brain and followed mRNA and protein levels and (intra)cellular location in developing brain in vivo as well as in differentiating neuronal cell cultures in vitro. In the interval between postnatal days P7 and P21, the steady-state level of DMWD mRNA remained constant, whereas the DMWD protein (doublet of 70 kDa) level gradually increased during the same period. The DMWD protein was expressed throughout the brain, at a low level in glial cells, more prominently in neurons and specifically in the neuropil of brain areas with a high density of synaptic connections. Intracellularly, DMWD was dispersed in a punctuate fashion throughout the neural cell body, the nucleus and the dendrites with their synapses, but was excluded from axons. Based on these findings and on new literature data concerning the role of DMWD homologs in lower eukaryotes, we discuss the possible role of DMWD in the brain-related symptoms seen in DM1 patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691844     DOI: 10.1016/s0006-8993(03)02430-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.

Authors:  Arturo López Castel; Masayuki Nakamori; Stephanie Tomé; David Chitayat; Geneviève Gourdon; Charles A Thornton; Christopher E Pearson
Journal:  Hum Mol Genet       Date:  2010-11-01       Impact factor: 6.150

2.  Functionally orthologous viral and cellular microRNAs studied by a novel dual-fluorescent reporter system.

Authors:  Xiangyu You; Zhiping Zhang; Jinyu Fan; Zongqiang Cui; Xian-En Zhang
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

3.  Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease.

Authors:  Mohsen Ghanbari; M Arfan Ikram; Hans W J de Looper; Albert Hofman; Stefan J Erkeland; Oscar H Franco; Abbas Dehghan
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

4.  Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1.

Authors:  Qi Yin; Hongye Wang; Na Li; Yifu Ding; Zhenfei Xie; Lifang Jin; Yan Li; Qiong Wang; Xinyi Liu; Liuqing Xu; Qing Li; Yongjian Ma; Yanbo Cheng; Kai Wang; Cuiqing Zhong; Qian Yu; Wei Tang; Wanjin Chen; Wenjun Yang; Fan Zhang; Chen Ding; Lan Bao; Bin Zhou; Ping Hu; Jinsong Li
Journal:  Cell Res       Date:  2019-12-18       Impact factor: 25.617

Review 5.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

Review 6.  The miRNA world of polyomaviruses.

Authors:  Ole Lagatie; Luc Tritsmans; Lieven J Stuyver
Journal:  Virol J       Date:  2013-08-28       Impact factor: 4.099

7.  Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis.

Authors:  Georg Auburger; Suzana Gispert; Nadine Brehm
Journal:  Parkinsons Dis       Date:  2016-03-01

Review 8.  Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.

Authors:  Laurène M André; C Rosanne M Ausems; Derick G Wansink; Bé Wieringa
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.